Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 135.01%4.01M | 3,397.88%13.22M | 1,255.43%2.37M | 141.65%4.82M | 160.45%2.56M | 90.41%1.71M | -45.69%378K | 130.17%175K | 375.66%1.99M | 231.42%981K |
| Net income from continuing operations | 117.94%1.37M | 240.35%160K | 440.04%3.45M | 90.67%-364K | -93.85%134K | 124.17%630K | 92.68%-114K | 47.08%-1.01M | 78.58%-3.9M | 118.91%2.18M |
| Operating gains losses | 5.03%-415K | 239.52%1.11M | -0.76%-527K | 35.78%-2.21M | 86.12%-456K | -321.83%-437K | -19,900.00%-792K | -47.74%-523K | -783.50%-3.44M | -536.25%-3.29M |
| Depreciation and amortization | 56.89%2.45M | 121.69%3.63M | 230.10%5.37M | 4.59%7.22M | 25.37%2.39M | 13.12%1.56M | -4.49%1.64M | -14.27%1.63M | 26.74%6.9M | 14.94%1.91M |
| Asset impairment expenditure | ---- | ---- | ---- | 49.32%436K | 164.24%436K | --0 | --0 | --0 | -93.49%292K | -96.32%165K |
| Unrealized gains and losses of investment securities | 82.35%-6K | 688.46%205K | -17,800.00%-179K | 104.72%5K | 103.11%14K | -107.28%-34K | 108.47%26K | -100.54%-1K | -154.64%-106K | -1,100.00%-450K |
| Remuneration paid in stock | 111.21%678K | 57.51%556K | 118.79%757K | 471.19%1.39M | --368K | 1,788.24%321K | 70.53%353K | 1,721.05%346K | -94.02%243K | --0 |
| Deferred tax | 1.94%315K | 192.12%1.19M | 285.76%1.17M | 2.24%1.32M | -34.06%304K | 4.04%309K | 65.04%406K | 4.86%302K | --1.29M | --461K |
| Other non cashItems | -177.00%-164K | -103.92%-14K | -108.21%-40K | -54.41%1.31M | -73.32%250K | -68.07%213K | -50.00%357K | -17.46%487K | 5.60%2.87M | 1,202.35%937K |
| Change In working capital | 141.57%276K | 792.12%7.55M | -809.65%-7.45M | -474.48%-3.02M | 12.82%-442K | -157.74%-664K | -1,230.49%-1.09M | 19.15%-819K | -748.15%-525K | -152.11%-507K |
| -Change in receivables | 243.72%1.26M | 905.26%6.89M | -825.55%-5.87M | -1,837.67%-2.54M | -23.60%-1.41M | -72.42%366K | -387.88%-855K | -69.07%-634K | 0.00%146K | -746.33%-1.14M |
| -Change in payables and accrued expense | 4.66%-982K | 382.20%666K | -755.14%-1.58M | 28.61%-479K | 52.59%972K | -481.92%-1.03M | 37.73%-236K | 71.00%-185K | -932.31%-671K | -19.97%637K |
| Tax refund paid | -157.59%-492K | -186.14%-1.16M | 23.81%-176K | 22.12%-1.27M | -4.46%-445K | 71.58%-191K | -64.23%-404K | 42.39%-231K | ---1.63M | ---426K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 135.01%4.01M | 3,397.88%13.22M | 1,255.43%2.37M | 141.65%4.82M | 160.45%2.56M | 90.41%1.71M | -45.69%378K | 130.17%175K | 375.66%1.99M | 231.42%981K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -766.33%-16.26M | 151.84%6.31M | -69.45%1.02M | 181.26%4.51M | -73.38%556K | 13.66%-1.88M | 248.20%2.51M | 188.09%3.33M | -63.91%-5.56M | 349.88%2.09M |
| Net PPE purchase and sale | -532.04%-19.2M | ---- | ---- | 41.82%-3.24M | -106.06%-204K | -2,820.19%-3.04M | --0 | --0 | 55.80%-5.57M | 91.93%-99K |
| Net business purchase and sale | --0 | ---- | ---- | 101.21%50K | --0 | 101.60%50K | --0 | ---- | -152.37%-4.12M | --1.02M |
| Net investment purchase and sale | --5K | 339.37%5.12M | -95.93%95K | --3.5M | --0 | --0 | --1.17M | --2.33M | --0 | --0 |
| Dividends received (cash flow from investment activities) | -8.47%1.02M | 12.39%1.19M | -7.34%922K | -5.27%3.92M | -35.04%760K | 4.82%1.11M | -24.45%1.06M | 94.34%995K | 208.96%4.14M | 604.82%1.17M |
| Net other investing changes | --1.91M | ---- | ---- | --283K | --0 | ---- | --283K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -766.33%-16.26M | 151.84%6.31M | -69.45%1.02M | 181.26%4.51M | -73.38%556K | 13.66%-1.88M | 248.20%2.51M | 188.09%3.33M | -63.91%-5.56M | 349.88%2.09M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 783.33%2.38M | 100.07%4K | 45.82%-3.07M | -512.51%-16.11M | -592.22%-4.62M | 47.83%-348K | -778.17%-5.47M | -744.41%-5.67M | -116.69%-2.63M | -110.00%-668K |
| Net issuance payments of debt | --0 | --0 | 40.00%-3M | -86,996.77%-27M | -1,700,100.00%-17M | --0 | -16,029.03%-5M | ---5M | -100.79%-31K | -99.97%1K |
| Net common stock issuance | ---- | ---- | ---- | --12.76M | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --2.21M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | 82.01%-70K | 87.21%-72K | 85.14%-99K | 25.26%-1.98M | 46.68%-361K | 42.37%-389K | 5.38%-563K | 4.99%-666K | -4.38%-2.65M | -22.42%-677K |
| Net other financing activities | 482.93%239K | -17.39%76K | --29K | 118.37%107K | -425.00%-26K | 412.50%41K | 2,966.67%92K | ---- | 109.06%49K | 101.88%8K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 783.33%2.38M | 100.07%4K | 45.82%-3.07M | -512.51%-16.11M | -592.22%-4.62M | 47.83%-348K | -778.17%-5.47M | -744.41%-5.67M | -116.69%-2.63M | -110.00%-668K |
| Net cash flow | ||||||||||
| Beginning cash position | 279.30%24.45M | -46.84%4.8M | -60.54%4.45M | -35.42%11.29M | -32.52%5.99M | -40.41%6.45M | -27.65%9.03M | -35.42%11.29M | 186.06%17.48M | -20.48%8.87M |
| Current changes in cash | -1,808.90%-9.87M | 855.20%19.54M | 114.75%319K | -9.48%-6.78M | -162.99%-1.51M | 73.41%-517K | -59.89%-2.59M | 57.02%-2.16M | -153.15%-6.19M | -60.87%2.4M |
| Effect of exchange rate changes | -176.27%-45K | 5,500.00%112K | 129.79%28K | -5,500.00%-54K | -290.91%-21K | --59K | 104.17%2K | -368.57%-94K | 100.36%1K | -93.85%11K |
| End cash Position | 142.75%14.54M | 279.30%24.45M | -46.84%4.8M | -60.54%4.45M | -60.54%4.45M | -32.52%5.99M | -40.41%6.45M | -27.65%9.03M | -35.42%11.29M | -35.42%11.29M |
| Free cash from | -1,042.29%-15.18M | 3,397.88%13.22M | 1,255.43%2.37M | 144.02%1.58M | 166.55%2.35M | -267.80%-1.33M | 199.21%378K | 103.59%175K | 73.28%-3.58M | 188.73%882K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.